Cardiology 10th European Stroke Organization Conference (ESOC) 2024 May 15-17, 2024 — Basel, Switzerland Stroke Therapy Targeted at Platelet Glycoprotein Still Considered Promising Despite Negative Trial Download 2 PowerPoint slides
Cardiology 10th European Stroke Organisation Conference (ESOC) 2024: Expert Interview Dr. Andrew Demchuk — Length: 08:46 ANNEXA-I Sub-Analyses: Balancing Unequal Risks in ICH Treatment Selection Watch Presentation
Cardiology 10th European Stroke Organisation Conference (ESOC) 2024 May 15-17, 2024 — Basel, Switzerland Balancing Relative Risk of Poor Functional Outcomes Guides Factor Xa Inhibitor Reversal Agent Selection Download 4 PowerPoint slides
Cardiology 15th World Stroke Congress 2023 Dr. Andrew Demchuk — Length: 07:26 Improved Bleeding Control with Specific Anti-FXa Reversal Agent: The ANNEXA-I Trial Watch Presentation
Cardiology 15th World Stroke Congress 2023 October 10-12, 2023 — Toronto, Ontario Reversal Agent for Factor Xa Inhibitors Mitigates Intracranial Bleeding in Phase 4 Trial Download 4 PowerPoint slides
Cardiology Heart Failure: Expert Interview Dr. Nathaniel Hawkins — Length: 07:46 CAN-HF Eligibility Analysis: A Call to Action for Optimizing GDMT Watch Presentation
Cardiology Heart Failure: Expert Review and Commentary from Published Literature Dr. Nathaniel Hawkins & Dr. Eileen O'Meara Opportunities to Improve Survival in Heart Failure in Canada Download 5 PowerPoint slides
Cardiology LDL-C: Expert Interview Dr. Beth L. Abramson — Length: 06:09 Lipid Lowering Strategies for Cardioprotection: Current Data and Future Expectations Watch Presentation
Cardiology LDL-C: Expert Discussion Dr. Arsenault & Dr. McPherson — Length: 08:06 A Novel Approach for Sustained Tight Control of LDL-C Watch Presentation
Cardiology American Heart Association (AHA) 2022 Scientific Sessions: Expert Interview Dr. Lawrence Leiter — Length: 05:10 Long-term Data Reaffirms the Benefits of siRNA Therapy on LDL-C Suppression Watch Presentation
Cardiology American Heart Association (AHA) 2022 Scientific Sessions November 5-7, 2022 — Chicago, Illinois Lipid-lowering Efficacy Sustained Over 4 Years with Twice-yearly Injections of a First-in-class Therapy Download 5 PowerPoint slides
Cardiology Heart Failure: Expert Discussion Dr. Lee & Dr. Heffernan — Length: 10:59 A Time for Change: Significant Care Gaps Remain in Treatment Optimization of Patients with Heart Failure Watch Presentation